175 related articles for article (PubMed ID: 21990969)
61. Baicalin suppresses expression of Chlamydia protease-like activity factor in Hep-2 cells infected by Chlamydia trachomatis.
Hao H; Aixia Y; Dan L; Lei F; Nancai Y; Wen S
Fitoterapia; 2009 Oct; 80(7):448-52. PubMed ID: 19524644
[TBL] [Abstract][Full Text] [Related]
62. Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells.
Wang J; Frohlich KM; Buckner L; Quayle AJ; Luo M; Feng X; Beatty W; Hua Z; Rao X; Lewis ME; Sorrells K; Santiago K; Zhong G; Shen L
Microbiology (Reading); 2011 Oct; 157(Pt 10):2759-2771. PubMed ID: 21737500
[TBL] [Abstract][Full Text] [Related]
63. Cleavage-dependent activation of a chlamydia-secreted protease.
Dong F; Pirbhai M; Zhong Y; Zhong G
Mol Microbiol; 2004 Jun; 52(5):1487-94. PubMed ID: 15165249
[TBL] [Abstract][Full Text] [Related]
64. Chlamydial protease-like activity factor--insights into immunity and vaccine development.
Murthy AK; Guentzel MN; Zhong G; Arulanandam BP
J Reprod Immunol; 2009 Dec; 83(1-2):179-84. PubMed ID: 19853923
[TBL] [Abstract][Full Text] [Related]
65. CPAF, HSP60 and MOMP antigens elicit pro-inflammatory cytokines production in the peripheral blood mononuclear cells from genital Chlamydia trachomatis-infected patients.
Cheong HC; Lee CYQ; Cheok YY; Shankar EM; Sabet NS; Tan GMY; Movahed E; Yeow TC; Sulaiman S; Wong WF; Looi CY; Gupta R; Hassan J; Arulanandam B; AbuBakar S
Immunobiology; 2019 Jan; 224(1):34-41. PubMed ID: 30477893
[TBL] [Abstract][Full Text] [Related]
66. The trans-Golgi SNARE syntaxin 10 is required for optimal development of Chlamydia trachomatis.
Lucas AL; Ouellette SP; Kabeiseman EJ; Cichos KH; Rucks EA
Front Cell Infect Microbiol; 2015; 5():68. PubMed ID: 26442221
[TBL] [Abstract][Full Text] [Related]
67. Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis.
Robertson DK; Gu L; Rowe RK; Beatty WL
PLoS Pathog; 2009 Nov; 5(11):e1000664. PubMed ID: 19936056
[TBL] [Abstract][Full Text] [Related]
68. Localization of Chlamydia trachomatis hypothetical protein CT311 in host cell cytoplasm.
Lei L; Qi M; Budrys N; Schenken R; Zhong G
Microb Pathog; 2011 Sep; 51(3):101-9. PubMed ID: 21605656
[TBL] [Abstract][Full Text] [Related]
69. Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease).
Bavoil PM; Byrne GI
Pathog Dis; 2014 Aug; 71(3):287-91. PubMed ID: 24942261
[TBL] [Abstract][Full Text] [Related]
70. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion.
Hackstadt T; Scidmore MA; Rockey DD
Proc Natl Acad Sci U S A; 1995 May; 92(11):4877-81. PubMed ID: 7761416
[TBL] [Abstract][Full Text] [Related]
71. The coiled-coil membrane protein golgin-84 is a novel rab effector required for Golgi ribbon formation.
Diao A; Rahman D; Pappin DJ; Lucocq J; Lowe M
J Cell Biol; 2003 Jan; 160(2):201-12. PubMed ID: 12538640
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of proteolytic activity of a chlamydial proteasome/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis.
Sharma J; Dong F; Pirbhai M; Zhong G
Infect Immun; 2005 Jul; 73(7):4414-9. PubMed ID: 15972540
[TBL] [Abstract][Full Text] [Related]
73. Orchestration of the mammalian host cell glucose transporter proteins-1 and 3 by Chlamydia contributes to intracellular growth and infectivity.
Wang X; Hybiske K; Stephens RS
Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 29040458
[TBL] [Abstract][Full Text] [Related]
74. Intranasal immunization with recombinant chlamydial protease-like activity factor attenuates atherosclerotic pathology following Chlamydia pneumoniae infection in mice.
Li W; Gudipaty P; Li C; Henderson KK; Ramsey KH; Murthy AK
Immunol Cell Biol; 2019 Jan; 97(1):85-91. PubMed ID: 30051926
[TBL] [Abstract][Full Text] [Related]
75. Induction and inhibition of CPAF activity during analysis of Chlamydia-infected cells.
Johnson KA; Lee JK; Chen AL; Tan M; Sütterlin C
Pathog Dis; 2015 Feb; 73(1):1-8. PubMed ID: 25663342
[TBL] [Abstract][Full Text] [Related]
76. Dynamin-mediated lipid acquisition is essential for Chlamydia trachomatis development.
Gurumurthy RK; Chumduri C; Karlas A; Kimmig S; Gonzalez E; Machuy N; Rudel T; Meyer TF
Mol Microbiol; 2014 Oct; 94(1):186-201. PubMed ID: 25116793
[TBL] [Abstract][Full Text] [Related]
77. Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion.
Ur-Rehman T; Slepenkin A; Chu H; Blomgren A; Dahlgren MK; Zetterström CE; Peterson EM; Elofsson M; Gylfe A
J Antibiot (Tokyo); 2012 Aug; 65(8):397-404. PubMed ID: 22669447
[TBL] [Abstract][Full Text] [Related]
78. [Early diagnosis using recombinant protein of immunodominant region gene of Chlamydial protease-like activity factor from Chlamydophila pneumoniae].
Zheng J; Wu Y; Liu J; Liu G; Chen C
Wei Sheng Wu Xue Bao; 2008 Apr; 48(4):520-5. PubMed ID: 18590240
[TBL] [Abstract][Full Text] [Related]
79. Neutralizing antichlamydial activity of complement by chlamydia-secreted protease CPAF.
Yang Z; Tang L; Zhou Z; Zhong G
Microbes Infect; 2016 Nov; 18(11):669-674. PubMed ID: 27436813
[TBL] [Abstract][Full Text] [Related]
80. Chlamydial infection induces host cytokinesis failure at abscission.
Brown HM; Knowlton AE; Grieshaber SS
Cell Microbiol; 2012 Oct; 14(10):1554-67. PubMed ID: 22646503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
